Membranoproliferative glomerulonephritis: current histopathological classification, clinical profile, and kidney outcomes.

J Bras Nefrol

Universidade Federal de São Paulo, Divisão de Nefrologia, São Paulo, SP, Brasil.

Published: May 2023

AI Article Synopsis

  • MPGN is a rare kidney disease classified based on immunoglobulin and complement deposits found in biopsies, with the study aiming to compare clinical characteristics and outcomes between primary and secondary cases.
  • In the studied cohort of 53 cases, 67.9% were classified as primary, with most showing common symptoms like hypertension and edema, while secondary cases frequently presented with hematuria and specific immunoglobulin deposits.
  • The study found that 39% of patients achieved remission, and worse kidney outcomes were linked to factors like low serum albumin and high proteinuria at the start.

Article Abstract

Introduction: Membranoproliferative glomerulonephritis (MPGN) is a rare glomerular disease with a variable prognosis. A new classification based on the presence or absence of immunoglobulins and complement deposits in immunofluorescence microscopy (IF) of kidney biopsy has recently been proposed. The objectives of the study were to determine and compare the clinical, laboratory, and histopathological characteristics of those with primary or secondary MPGN, reclassify the primary ones based on IF findings, and evaluate kidney outcomes.

Methods: This was an observational retrospective cohort study carried out in a single center (UNIFESP), based on the data collected from medical records of patients followed from 1996 to 2019.

Results: Of 53 cases of MPGN, 36 (67.9%) were classified as primary and 17 (32.1%) as secondary MPGN. Most patients were hypertensive (84.9%) and had edema (88.7%) and anemia (84.9%); 33 (91.7%) patients classified as primary MPGN were reclassified as immune-complex-mediated and 3 (8.3%) as complement-mediated. The secondary MPGN group had hematuria more frequently (p <0.001) and a higher prevalence of deposits of IgG (p = 0.02) and C1q (p = 0.003). Regarding the outcome, 39% of the patients achieved partial or complete remission. Lower initial serum albumin and higher initial 24-hour proteinuria were factors associated with worst renal prognosis.

Conclusions: According to the new histological classification, the vast majority of MPGN cases were classified as being mediated by immune complexes. There were few differences between primary and secondary MPGN in relation to their clinical and laboratory characteristics.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139719PMC
http://dx.doi.org/10.1590/2175-8239-JBN-2022-0016enDOI Listing

Publication Analysis

Top Keywords

secondary mpgn
12
membranoproliferative glomerulonephritis
8
classified primary
8
mpgn
6
glomerulonephritis current
4
current histopathological
4
histopathological classification
4
classification clinical
4
clinical profile
4
profile kidney
4

Similar Publications

Article Synopsis
  • Membranous proliferative glomerulonephritis (MPGN) is a rare kidney condition characterized by specific pathological changes, observed in a 77-year-old man with mild proteinuria and hematuria.
  • Laboratory tests indicated elevated MPO-ANCA levels and a renal biopsy showed distinct features that confirmed MPGN type 3.
  • The patient responded well to treatment with an SGLT2 inhibitor and the case raises questions about the association between high MPO-ANCA levels and latent tuberculosis infection, suggesting a potential link that needs further investigation.*
View Article and Find Full Text PDF

Hepatitis C-Induced Immunoglobulin A (IgA) Nephropathy: An Uncommon Cause of Hematuria.

Cureus

September 2024

General Medicine, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, IND.

Article Synopsis
  • IgA nephropathy, or Berger's disease, is marked by IgA deposits in the kidney and can lead to serious conditions like rapidly progressive glomerulonephritis.
  • Hepatitis C virus (HCV) is mainly known for liver issues but can also cause renal problems; however, IgA nephropathy linked to HCV is rare.
  • A case study of a 24-year-old man with untreated HCV showed serious kidney issues leading to a diagnosis of IgA nephropathy, but treatment improved his condition, highlighting the need for awareness and early intervention in HCV-related kidney complications.
View Article and Find Full Text PDF
Article Synopsis
  • The study classifies membranoproliferative glomerulonephritis (MPGN) into two types: immune complex-mediated and complement-mediated, based on immunofluorescence results, using data from a 20-year period at a major medical institution in Pakistan.
  • Out of 213 patients, the majority (76.5%) were found to have immune complex-mediated MPGN, with both groups showing similar demographics and clinical presentations, but differing treatment outcomes.
  • Immune complex-mediated MPGN had better remission rates and renal survival compared to complement-mediated MPGN, which had higher progression to end-stage kidney disease (ESKD) and greater overall mortality.
View Article and Find Full Text PDF
Article Synopsis
  • A middle-aged woman diagnosed with breast cancer developed worsening kidney issues, leading to nephrotic syndrome characterized by proteinuria and hematuria.
  • After receiving hormone therapy for her cancer, a kidney biopsy showed signs of IgA nephropathy, ruled out other potential causes.
  • Following breast cancer surgery and radiation, her kidney symptoms improved significantly, indicating a possible paraneoplastic glomerulopathy related to her breast cancer.
View Article and Find Full Text PDF

Membranoproliferative glomerulonephritis (MPGN) is a rare glomerular disease characterized by mesangial hypercellularity and thickening of the glomerular basement membrane (GBM). MPGN can be idiopathic or associated with malignancy, systemic immune complex disorders and chronic infections. It has rarely been associated with solid organ tumors, such as lung, gastric, breast or prostate cancer.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!